Literature DB >> 6662132

Consequences of uncontrolled calcium entry and its prevention with calcium antagonists.

A Fleckenstein, M Frey, G Fleckenstein-Grün.   

Abstract

Heart muscle fibres always undergo severe functional and structural alterations, finally resulting in necrotization, if free extracellular Ca2+ ions penetrate abundantly through the sarcolemma membrane into the myoplasm, so that the capacities of the Ca2+ binding or extrusion processes become overpowered. The crucial reaction consists of high-energy phosphate exhaustion which is brought about (a) by excessive activation of Ca2+-dependent intracellular ATPases, and (b) by Ca2+-induced impairment of the mitochondria. Intracellular Ca2+ overload proved to the common denominator in the pathogenesis of severe myocardial fibre injury and death produced under the following circumstances: Overdoses of beta-adrenergic catecholamines, dihydrotachysterol or vitamin D3, alimentary K+ or Mg2+ deficiency, hereditary cardiomyopathy of Syrian hamsters. Moreover, intracellular Ca2+ overload develops in the course of myocardial hypoxia or ischaemia thus causing additional precipitous damage of the mitochrondria. Following our first observations made in 1968, it has turned out that in all these cases, Ca2+ antagonists are capable of protecting myocardial cell integrity in that they prevent excessive transmembrane Ca2+ uptake. This is also true of the Ca2+ paradox: Ca2+ antagonists possibly inhibit the development of sarcolemmal leaks in the Ca2+-deprived myocardium. However, it is more likely that Ca2+ antagonists restrict the exaggerated influx of Ca2+ through these leaks, when the Ca+-deprived myocardial fibres return to a normal Ca2+-containing medium.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6662132     DOI: 10.1093/eurheartj/4.suppl_h.43

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  21 in total

1.  Calcium-induced damage of skeletal muscle fibers is markedly reduced by calcium channel blockers.

Authors:  M Soza; G Karpati; S Carpenter; S Prescott
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

2.  Reversible cardiomyopathy complicating intrathecal baclofen withdrawal: a case report.

Authors:  Anthony F Pizon; Frank Lovecchio
Journal:  J Med Toxicol       Date:  2007-12

Review 3.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 4.  Calpain system and its involvement in myocardial ischemia and reperfusion injury.

Authors:  Christiane Neuhof; Heinz Neuhof
Journal:  World J Cardiol       Date:  2014-07-26

5.  Isoproterenol induces primary loss of dystrophin in rat hearts: correlation with myocardial injury.

Authors:  Erica C Campos; Minna M D Romano; Cibele M Prado; Marcos A Rossi
Journal:  Int J Exp Pathol       Date:  2008-10       Impact factor: 1.925

6.  Diltiazem and verapamil prevent vitamin D3-induced myocardial calcium overload in rat papillary muscle: assessment with PVC ETH-123 calcium-selective microelectrodes.

Authors:  R Gasser; Y K Byon; G Frey; G Fleckenstein-Grün; A Fleckenstein
Journal:  Cardiovasc Drugs Ther       Date:  1996-05       Impact factor: 3.727

7.  Intracellular Ca2+ thresholds that determine survival or death of energy-deprived cells.

Authors:  Z Dong; P Saikumar; G A Griess; J M Weinberg; M A Venkatachalam
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

8.  Mechanisms of low Na(+)-induced increase in intracellular calcium in KCl-depolarized rat cardiomyocytes.

Authors:  Satyajeet S Rathi; Harjot K Saini; Yan-Jun Xu; Naranjan S Dhalla
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

Review 9.  Diltiazem. A review of its pharmacological properties and therapeutic efficacy.

Authors:  M Chaffman; R N Brogden
Journal:  Drugs       Date:  1985-05       Impact factor: 9.546

Review 10.  Myofibroblast-mediated mechanisms of pathological remodelling of the heart.

Authors:  Karl T Weber; Yao Sun; Syamal K Bhattacharya; Robert A Ahokas; Ivan C Gerling
Journal:  Nat Rev Cardiol       Date:  2012-12-04       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.